Two subgroup F avian leukosis viruses, ring-necked pheasant virus (RPV) and RAV-61, were previously shown to induce a high incidence of a fatal proliferative disorder in the lungs of infected chickens. These lung lesions, termed angiosarcomas, appear rapidly (4 to 5 weeks after infection), show no evidence of protooncogene activation by proviral integration, and are not induced by avian leukosis viruses belonging to other subgroups. To identify the viral sequences responsible for induction of these tumors, we constructed recombinant viruses by exchanging genomic segments of molecularly cloned RPV with those of a subgroup A leukosis virus, UR2AV. The ability to induce rapid lung tumors segregated only with the env sequences of RPV; the long terminal repeat of RPV was not required. However, recombinants carrying both env and long terminal repeat sequences of RPV induced lung tumors with a shorter latency. In several cases, recombinant viruses exhibited pathogenic properties differing from those of either parental virus. Recombinants carrying the gag-pol region of RPV and the env gene of UR2AV induced a high incidence of a muscle lesion termed infiltrative intramuscular fibromatosis. One recombinant, EU-8, which carries the gag-pol and LTR sequences of RPV, and the env gene of UR2AV, induced lymphoid leukosis after an unusually short latent period. The median time of death from lymphoid leukosis was 6 to 7 weeks after infection with EU-8 compared with approximately S months for UR2AV.
Avian retroviruses cause a variety of neoplastic and nonneoplastic disorders in the infected animal. The acute leukemia viruses and sarcoma viruses, which carry oncogenes, rapidly induce neoplastic diseases (within 1 to 4 weeks) at frequencies approaching 100%. The avian leukosis viruses (ALVs), which do not carry oncogenes, usually induce neoplasia after a latent period of 4 to 12 months, and the incidence of neoplasia is generally lower (20 to 80%) than that of the acute viruses. The most common neoplasm in ALV-infected chickens is lymphoid leukosis (a B-cell lymphoma originating in the bursa of Fabricius), but other diseases such as nephroblastoma, fibrosarcoma, osteopetrosis, and erythroblastosis also occur (3, 50) . The spectrum and incidence of these neoplasms are influenced by a number of factors, including virus strain, virus titer, site of inoculation, and the age and genetic makeup of the host (2, 9, 50) .
The subgroup F avian leukosis viruses, i.e., RAV-61, W8-1-lB, and ring-necked pheasant virus (RPV), were originally isolated from pheasant cells infected with the Bryan strain of Rous sarcoma virus (23, 28, 35) . These recombinant viruses lack an oncogene but have acquired certain retroviral sequences endogenous to the ring-necked pheasant. and RPV have an unusually high oncogenic potential (10, 62) . Chickens infected with either of these viruses as 10-dayold embryos develop a high incidence (88% in one experiment) of a proliferative disorder involving the lung. The lung lesions consist of localized foci of anaplastic vascular endothelial cells and have been histopathologically diagnosed as angiosarcomas. Proliferating foci are detected as early as 2 weeks after hatching. Many infected chickens die rapidly, with their lungs filled with proliferating cells. Approximately 70% of the infected birds die between 3 and 10 weeks of age, which is unusually rapid for ALV-induced disease. The deaths correlate with the appearance of severe lung foci. Chickens living 6 weeks or longer have smaller lung lesions, if any, and develop long-latency disorders, such as lymphoid leukosis, nephroblastoma, and fibrosarcoma.
The long-latency neoplasms in subgroup F virus-infected chickens have been analyzed, and each is a monoclonal expansion of a single transformed cell (62) . The majority of fibrosarcomas tested appear to contain RPV proviruses integrated at a common site, and several tumors contained novel long-terminal-repeat (LTR)-initiated transcripts (62) . This suggests that a specific, as yet unidentified, host protooncogene is activated by proviral integration in a manner similar to that described for the c-myc gene in ALV-induced lymphoid leukosis (30) and c-erbB in ALV-induced erythroblastosis (25, 46) . RPV-induced lymphomas and an abdominal adenocarcinoma contained proviruses integrated at the c-myc locus and elevated levels of myc mRNA (62) . In contrast to the long-latency tumors, the rapidly appearing lung angiosarcomas show no evidence of clonality and lack LTR-initiated transcripts other than viral 35S and 21S mRNA (62) . Therefore, it seems likely that lung tumors in RPV-or RAV-61-infected chickens arise by some mechanism that does not involve activation of host protooncogenes.
Angiosarcomas have been observed in chickens infected with retroviruses carrying the c-erbB (69) or polyomavirus middle T (36) (27) and maintained at 37°C in F-10 medium supplemented with 5% calf serum and 1% chick serum. RPV, obtained from P. K. Vogt (23) , was plaque purified three times on C/ABE fibroblasts and once on turkey embryo fibroblasts (56) .
Molecular cloning of circular RPV proviral DNA. Chicken embryo fibroblast (CEF) cells were seeded at 5 x 106 cells per 10-cm plate. After S h, cells were treated with 17 ,ug of DEAE-dextran per ml and infected with RPV at a multiplicity of infection of 3 to 4. The medium was changed after 24 h, and at 48 h postinfection unintegrated circular proviral DNA was isolated by Hirt fractionation (31, 59). The Hirt supernatant was extracted by acid phenol (45) to remove contaminating linear DNA fragments greater than 1 to 2 kilobases (kb). Linear DNA less than 1 kb in size was removed by gel filtration on a 100/200 mesh column (A5M; Bio-Rad Laboratories, Richmond, Calif.) (45) . SacI-digested RPV proviral DNA (1 jig) was ligated to 2 ,ug of Sacl arms of the bacteriophage vector Xgt WES (37) . The ligation mixture was packaged in vitro (37, 59) , and 5 x 104 plaques were screened with 32P-labeled RAV-2 DNA (4). Two recombinant clones, i.e., ARPV-1 and XRPV-12, were obtained and characterized further. The 7.6-kb viral DNA insert of XRPV-12 was subcloned into a unique Sacl site of plasmid pUC12. A lambda clone of a subgroup ALV UR2AV (45) , was also subcloned into pUC12 at the Sacl site. The resultant subclones were designated pRPV and pUR2AV.
To confirm the identity of the RPV clones, SacI inserts were purified from vector DNA and tested by restriction endonuclease digestions. Both XRPV-1 and XRPV-12 contained 7.6-kb inserts. The SalI insert of plasmid pRAV-2 is 7.6 kb (34); the Sacl insert of XUR2AV-14-1 is 7.9 kb (45) . It was previously shown that this RAV-2 clone contains a single LTR (34) , whereas XUR2AV contains two LTRs (45) . Therefore, it was most likely that XRPV-1 and XRPV-12 contained full-length copies of a circular proviral intermediate with one LTR. Alternatively, clones 1 and 12 were derived from circular intermediates with two LTRs and suffered recA-independent deletions of nucleotide sequences during cloning (8) . The structure of the RPV Sacl insert is shown in Fig. 1 This was mixed with a 3.2-kb KpnI-SacI fragment from pLUR-9 (consisting of env and LTR sequences), ligated, and introduced into JM109. All colonies screened showed the appropriate 7.9-kb Sacl insert which lacked MstII sites in the LTR region.
Constructs pER-9 and pLU-6 were derived from pUR2AV'. A 3.7-kb MstII fragment from pUR-6 was substituted for the 3.7-kb fragment of pUR2AV', giving pER-9. Then pER-9 was digested with BgiII and Sall; a 6.6-kb SaiI-BglII piece was ligated to the 4.0-kb SalI-BglII fragment from pRPV to produce pLU-6.
All 10 clones (pRPV, pUR2AV, pUR2AV', pRU-9, pK-3, pUR-6, pEU-8, pLR-9, pER-9, and pLU-6) were tested by extensive restriction mapping to verify that they had the predicted restriction sites. Plasmids were colony purified and amplified in JM109 by standard procedures (43) . CEF transfection and virus production. CEFs lacking endogenous proviruses (ev-) were used for virus production to eliminate the possibility of in vivo recombination between RPV and endogenous viral genomes. pUR2AV, pRPV, and recombinant virus constructs were cut with Sacl and purified by agarose gel electrophoresis. Samples (2 ,g) of each DNA were ligated briefly in 20 p1 of standard ligation buffer at 15°C for 30 min as previously described (14) . One-half of each ligation reaction was mixed with 20 ,ug of salmon sperm DNA and added to 800 ,ul of 125 mM CaCl2-20 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid [pH 7.0])-137 mM NaCl-5 mM KCl-0.59 mM Na2HPO4 (26, 45) . After a 15-min incubation at room temperature, each mixture was added to ev-CEF cells that had been seeded 24 h earlier at 8 x 105 cells per 60-mm culture dish. Each dish contained 5 ml of F-10 medium lacking tryptose phosphate broth. This medium was replaced 4 to 5 h later with normal F-10 medium. As they became confluent, transfected cells were transferred to 100-mm dishes and passaged three more times (in 12 to 14 days).
Virus growth was monitored by assaying tissue culture supernatants for the presence of reverse transcriptase activity (71) .
Inoculation of chickens. The chickens used were White Leghorns from the experimental SC line (Hyline International, Dallas Center, Iowa). After a 10-day incubation, fertile eggs received 0.1 ml of a virus suspension (106 PFU/ml) intravenously. Infected embryos were incubated another 10 to 11 days and then transferred to a separate room of an isolation facility for hatching and maintenance. Chickens inoculated with viruses having different subgroup specificities were maintained in separate rooms and observed for disease for 6 months to a year. Postmortem examinations were performed on all chickens. Tissues were placed in 10% buffered Formalin and processed for histopathologic analyses (10) .
RESULTS
Molecular cloning of RPV DNA. Two lambda recombinant phage clones, designated XRPV-1 and XRPV-12, were purified by three cycles of single-plaque isolation and used for further study. To test for biological activity, insert DNAs were transfected onto ev-CEFs by calcium phosphate coprecipitation. After four transfers (about 15 days), supernatant fluids from transfected cells were assayed for the presence of reverse transcriptase. Media from all cultures contained reverse transcriptase activity, indicating that both clones gave rise to replicating, fully infectious virus. Titers of supernatants were also determined by plaque formation and endpoint dilution. When 10-day-old embryos were infected with 104 PFUs of the RPV-12 virus, 10 of 11 chickens developed lung tumors after hatching and 2 of 11 developed muscle fibrosarcomas. Thus, the molecularly cloned RPV induced incidences of angiosarcoma and fibrosarcoma similar to those observed for the original virus stocks (10) .
Homology between the subgroup F env gene and env genes of other ALVs. The ability to cause lung foci rapidly and efficiently seems to be specific to subgroup F ALV. Other ALVs tested have failed to elicit the disease spectrum of RPV and RAV-61 (R. Smith, unpublished data).
Previous studies by liquid hybridization with a cDNA probe specific for certain RAV-61 sequences suggest that the sequences have no homology to the genome of ALVs in subgroups A, B, C, D, and E and that they are probably derived from pheasant DNA (35, 60, 61) . The pheasantderived sequences appear to constitute approximately 22 to 25% of the genome of both RAV-61 and another subgroup F virus, W8-1-lb (35) . These sequences are large enough to accommodate the entire env gene in both viruses, but it was not clear from the early studies whether the pheasantderived sequences provide envelope information exclusively. Furthermore, short regions of homology or regions of partial homology between the subgroup F env gene and those of other ALVs would not have been detected under the conditions used.
To further characterize these sequences, we compared cloned RPV DNA with DNA clones of UR2AV (subgroup A) and RAV-2 (subgroup B). As shown previously (62), restriction sites in the RAV-2 genome are conserved in gag, pol, and the LTRs of RPV and RAV-61. Restriction sites in the env gene of RPV and RAV-61 differ from those in the RAV-2 env gene. Whereas U5, gag, and pol probes hybridized to RPV proviral DNA (data not shown), a probe specific for subgroup A envelope sequences did not hybridize to some portions of the env region of the RPV clone. Proviral structures of the Sacl inserts of XUR2AV-14-1 and XRPV-12 are shown in Fig. 1A . The subgroup A probe penv is also shown in Fig. 1A . 32P-labeled penv hybridized readily to appropriate restriction fragments derived from the 7.9-kb UR2AV Sacl insert. These include a 3.2-kb KpnI fragment, the 2.6-and 1.8-kb BamHI fragments, and a 5.5-kb HincII fragment (Fig. 1C, lanes 4 , 5, and 6). penv also hybridized to analogous restriction fragments derived from the Sall insert of pRAV-2 (data not shown). This probe hybridized with much less intensity to restriction fragments generated from the envelope region of the RPV clone (Fig. 1C, lanes 1, 2,  and 3) . The 1.7-and 0.9-kb KpnI fragments, the 1.9-and 1.8-kb BamHI doublet, and the 3.5-and 0.7-kb HincIl fragments hybridized only weakly to penv. A 200-bp KpnI fragment (too small to be detected by ethidium bromide staining of this gel) and a 600-bp BamHI fragment (Fig. 1B , open arrow, lane 2) did not show any hybridization to penv, even after a 24-h exposure.
The 600-bp BamHI fragment was subcloned into the BamHI site of pUC12; this plasmid was designated pB2. After elution of the penv probe, 32P-labeled pB2 (Fig. 1A) was hybridized to the same nitrocellulose filter. Plasmid pB2 detected the 0.9-kb and 200-bp KpnI fragments, the 600-bp BamHI fragment, and the 3.5-kb HincII fragments of RPV, as expected (Fig. 1D, lanes 1, 2, and 3 An unexpected result was the development of proliferative lesions in the breast muscle of a large number (54%) of K-3-infected chickens. On histopathologic examination, these muscle growths appeared to possess a distinct cellular morphology, which ranged from threadlike lesions, barely discernable to the unaided eye, to large, firm nodules. The threadlike lesions, which often gave the muscle a ropelike appearance, were termed infiltrative intramuscular fibromatosis (Table 1) (N. Kogekar, T. L. Spurgeon, M. C. Simon, and R. E. Smith, Cancer Res., in press). More advanced lesions were considerably larger and frequently appeared as elliptical, white, firm masses and were termed nodular fibromatosis. A number of RU-9-infected chickens (31%) also developed these tumors in their breast muscles.
It is interesting that neither parental virus induced a high incidence of infiltrative intramuscular fibromatosis in infected chickens. The two recombinants that induced the disease contain gag and pol sequences from RPV and env and LTR sequences from UR2AV. They differ by approximately 700 bp of genetic information in the pol region; K-3 contains 700 nucleotides more of the RPV genome than RU-9 does, because the KpnI site rather than the BglII site was used to make this construct ( Fig. 2A) .
Characterization of the LR-9, LU-6, ER-9, and EU-8 recombinant viruses. To distinguish between the contributions of the RPV env and LTR sequences, we constructed several additional recombinants shown in Fig. 2B (Fig. 2) ; LU-6 also contains RPV-derived gag and pol sequences, with only the LTR sequences derived from UR2AV; ER-9 contains env sequences as the sole determinant contributed by RPV. Thus, it appears that the subgroup F envelope is the primary determinant of angiosarcoma. LR-9, which contains the RPV LTR but all other sequences from UR2AV', did not induce a high incidence of lung tumors (1 of 23) . The data demonstrate that the RPV env gene is necessary for angiosarcoma induction but the RPV LTR is not. Rapid appearance of lymphoid leukosis in EU-8-infected chickens. One of the recombinant viruses, EU-8, induced a high incidence (36 of 49 birds; 73%) of lymphoid leukosis after a remarkably short latent period. The median time of death from these neoplasms was 6.5 weeks after infection, and deaths occurred as early as 4 to 5 weeks (data not shown). EU-8 contains the env gene of UR2AV, but all other sequences are from RPV. Lymphoid leukosis was also found at early times in birds infected with two other recombinants, K-3 and RU-9, both of which contain gag-pol sequences from RPV but env and LTR sequences from UR2AV. The incidence of early lymphoid leukosis, however, was significantly lower than with EU-8.
Incidence of neoplasia in birds sacrificed at 6 weeks. To further investigate the incidence of neoplasia at early times after infection, a second experiment was carried out in which all surviving chickens were sacrificed and necropsied 6 weeks after hatching. Data obtained from birds infected with RPV and with constructs K-3, UR-6, LR-9, UR2AV', ER-9, and EU-8 are compiled in Table 2 . In this study, 78% of the RPV-infected chickens developed lung angiosarcomas during the first 6 weeks after hatching, whereas none of the 14 UR2AV'-infected chickens showed any sign of lung tumors. One lymphoma was detected in a bird infected with UR2AV'. However, 7 of 18 (39%) chickens infected with EU-8 developed lymphoid leukosis within the first 6 weeks. Four of these birds died before the termination of the experiment at 6 weeks. A fairly high incidence (22%) of lymphoid leukosis was also found in K-3-infected birds. The VOL. 61, 1987 tumors in these birds, however, were generally much smaller than those in the EU-8-infected birds. EU-8 also caused a high incidence of infiltrative intramuscular fibromatosis (61% in the long-term experiment and 89% in the 6-week experiment). This is interesting because of the genetic relatedness of EU-8 and the other construct, K-3, which produced a high incidence of infiltrative intramuscular fibromatosis (76% of K-3-infected animals in the 6-week study). Both viruses contain RPV-derived sequences up to the KpnI site and an env gene from UR2AV (Fig. 2) . EU-8 differs from K-3 in that it also contains RPV-derived LTRs. Apparently, exchanging the RPV LTR for the UR2AV LTR did not affect the ability of K-3 to cause infiltrative intramuscular fibromatosis.
Virus UR-6 induced a 67% incidence of lung tumors in chickens in the 6-week experiment, consistent with the high incidence of angiosarcoma that appeared in the same test group (Table 1) . However, some evidence of early-stage lung lesions was also detected in birds inoculated with K-3 and LR-9 ( Table 2 ). This is not consistent with the findings reported in Table 1 . The clusters of hyperplastic endothelial cells noted in the lungs of K-3-and LR-9-infected chickens, however, were detected only by necropsy of birds sacrificed at 6 weeks and did not cause death in any experiments. Early stages of the disease may develop in chickens infected with certain recombinants that do not carry the RPV env gene, but these tumors presumably regress and are not lethal. On the basis of the data compiled in Table 1 (18) . These domains have been termed hrl and hr2 (18) ; hrl begins at base 5654 and encodes 32 (15, 42) . In addition, the RPV LTR contained an 11-bp insertion downstream from the first 88 bp and a number of single-base mutations.
To determine the contribution of different genetic regions to the pathogenic properties of RPV, we constructed recombinant viruses by exchanging segments from different portions of the RPV genome with those of UR2AV, a subgroup A ALV. Results of these studies are summarized in Fig. 3 (21, 41, 72) , and a number of isolates of replication-competent, env gene recombinants are believed to be the proximal agents causing leukemias and lymphomas in MuLV-infected mice (11, 20, 70 (21) , which are invariably found in leukemic tissues (22, 53, 70) . In addition, two strains of replication-defective, highly pathogenic derivatives of MuLV have been isolated, the Friend and Rauscher spleen focus-forming viruses (5, 66, 67) . These defective viruses encode altered envelope glycoproteins that appear to be responsible for their pathogenic properties (19, 41, 48, 54, 55) .
Recent evidence froth recombinants constructed in vitro has indicated that both the env gene and U3 regions of MuLV contribute to oncogenicity (11, 16, 17, 32, 39, 49) . Several models have been proposed to explain these observations. For example, the recombinant MCF-type envelope gene products might be necessary for viral infection of appropriate target cells. U3 enhancer sequences may then function in a cell-type-specific manner in LTR-mediated activation of cellular oncogenes (16, 49 (72) or by causing an altered sensitivity to hematopoietic growth factors (33) . In these cases, U3 enhancers might serve to increase gp7O expression in specific target cells (49) .
RPV-induced lung tumors are nonclonal with respect to proviral integrations, and insertional activation of a single host proto-oncogene is therefore unlikely (62) . The The progressive nature of lung angiosarcomas noted in RPV-infected chickens is similar to that observed with angiosarcoma in the breast (44) . There were possible examples of metastases from the lung to the liver in several RPV-infected birds, but the possibility that the liver tumors represented liver endothelial cell angiosarcomas could not be excluded. Thus, RPV-induced lung angiosarcoma appears to be a proliferative, highly fatal disease that is not highly metastatic.
Recombinant viruses induced fibromatosis and shortlatency B-cell lymphoma. The disease spectra of three closely related recombinant viruses, i.e., K-3, RU-9, and EU-8, were unexpected. All three viruses induced a high incidence of a neoplasia not previously detected at high frequencies in chickens infected with either parent virus. A (50) and 5 months for the UR2AV parent used in these studies. A high incidence of rapid lymphoid leukosis was found only with the recombinant (EU-8) that carries gag-pol and LTR sequences from RPV and env sequences from UR2AV. Early lymphomas were also induced, at lower frequency and with longer latency, by two recombinants (K-3 and RU-9) that carry only gag-pol sequences from RPV. However, a recombinant (LR-9) containing LTR sequences from RPV but all other sequences from UR2AV induced only a single lymphoma among 20 birds tested in the short-term experiment (Table 2) . No early lymphomas were detected among 23 birds in the long-term study.
These experiments indicate that the gag-pol region of RPV contains sequences that are responsible for the rapid induction of lymphoid leukosis. The nature of these sequences, however, is unknown. The gag and pol regions have also been implicated as determinants of pathogenicity in other retrovirus systems (32, 47, 51, 52) . It is interesting that several laboratories have found evidence for the presence of regulatory sequences within this portion of the viral genome (1, 7, 30a) .
Unlike the rapidly appearing lung angiosarcomas, the early lymphomas are clonal with respect to proviral integrations (M. Kanter, R. E. Smith, and W. S. Hayward, unpublished results). In most cases, they do not involve proviral integrations in the vicinity of c-myc (Kanter et al., unpublished results). It is interesting that the rapidly appearing lymphomas, unlike the long-latency B-cell lymphomas induced by other ALVs, do not appear to originate in the bursa. Thus, the rapid lymphoma may result from a very efficient insertional activation mechanism. The putative regulatory sequences located within the gag-pol region could play an important role in this process, but a direct role for one or more of the gag or pol gene products must also be considered. Experiments are in progress to identify more precisely the sequences involved.
The ability of RPV to induce a wider spectrum of neoplastic diseases than most ALVs makes this virus attractive for further study. The rapid onset, the high frequency of induction, and the unusual site of tumor formation make RPV-induced angiosarcomas a unique example of ALVinduced disease. Furthermore, the novel pathogenic properties of several of the recombinant viruses described here provide useful material for further dissecting the genetic basis for a variety of virus-induced neoplastic diseases.
